149 related articles for article (PubMed ID: 17451941)
21. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
[TBL] [Abstract][Full Text] [Related]
23. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.
Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S
Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998
[TBL] [Abstract][Full Text] [Related]
24. The role of ThinPrep cytology in the investigation of lung tumors.
Konofaos P; Tomos P; Malagari K; Karakatsani A; Pavlopoulos D; Lachanas E; Flessas M; Kostakis A; Karakitsos P
Surg Oncol; 2006 Nov; 15(3):173-8. PubMed ID: 17275290
[TBL] [Abstract][Full Text] [Related]
25. [Determination of estrogen receptor status in breast cancer by immunocytochemical examination of fine-needle aspirates].
Balslev E; Nielsen M; Jensen OJ; Francis D; Thorpe SM
Ugeskr Laeger; 1992 Nov; 154(48):3395-8. PubMed ID: 1462448
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
Alkuwari E; Auger M
Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
[TBL] [Abstract][Full Text] [Related]
27. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma.
Bueno Angela SP; Viero RM; Soares CT
Cytopathology; 2013 Feb; 24(1):26-32. PubMed ID: 22220518
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947
[TBL] [Abstract][Full Text] [Related]
30. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
[TBL] [Abstract][Full Text] [Related]
31. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer.
Park SY; Kim KS; Lee TG; Park SS; Kim SM; Han W; Noh DY; Kim SW
Am J Surg; 2009 Feb; 197(2):266-9. PubMed ID: 18614146
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations.
Hanley KZ; Birdsong GG; Cohen C; Siddiqui MT
Cancer; 2009 Aug; 117(4):279-88. PubMed ID: 19551847
[TBL] [Abstract][Full Text] [Related]
33. The use of fine needle aspirates in the evaluation of progesterone receptor content in breast cancer.
Lozowski M; Greene GL; Sadri D; Stanick D; Pai P; Harris MA; Lundy J
Acta Cytol; 1990; 34(1):27-30. PubMed ID: 2404374
[TBL] [Abstract][Full Text] [Related]
34. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
[TBL] [Abstract][Full Text] [Related]
35. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay.
Sauer T; Beraki E; Jebsen PW; Amlie E; Harbitz T; Kåresen R; Naess O
Anal Quant Cytol Histol; 1998 Apr; 20(2):122-6. PubMed ID: 9569969
[TBL] [Abstract][Full Text] [Related]
36. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
37. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy.
Usami S; Moriya T; Amari M; Suzuki A; Ishida T; Sasano H; Ohuchi N
Jpn J Clin Oncol; 2007 Apr; 37(4):250-5. PubMed ID: 17485439
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of estrogen receptors in cells obtained by fine needle aspiration from human mammary carcinomas.
Azavedo E; Baral E; Skoog L
Anticancer Res; 1986; 6(2):263-6. PubMed ID: 3518595
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
40. Ultrasonographically and stereotactically guided fine-needle aspiration cytology of non-palpable breast lesions: cyto-histological correlation.
Pogacnik A; Strojan Flezar M; Rener M
Cytopathology; 2008 Oct; 19(5):303-10. PubMed ID: 17944953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
